3 Biotech Stocks That Could Pop in a Heartbeat
Biotech stocks have been on a tear lately, with the
SPDR S&P Biotech (ETF)
(NYSEARCA:
) outrunning the
S&P 500
about 45% to 10% over the past 10 months. And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For perspective, the S&P 500 only boasts 41% on that front, and the
Dow Jones Industrial Average
only 33%.
http://investorplace.com/2015/03/biotech-stocks-xbi-mygn-thrx-ghdx/view-all/#.VQPbJOnwuUk
Continue reading:
3 Biotech Stocks That Could Pop in a Heartbeat
See which stocks are being affected by Social Media
